2018
DOI: 10.4103/0366-6999.230727
|View full text |Cite
|
Sign up to set email alerts
|

Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease

Abstract: Objective:Worldwide, community-acquired pneumonia (CAP) is a common infection that occurs in older adults, who may have pulmonary comorbidities, including chronic obstructive pulmonary disease (COPD). Although there have been clinical studies on the coexistence of CAP with COPD, there remain some controversial findings. This review presents the current status of COPD in CAP patients, including the disease burden, clinical characteristics, risk factors, microbial etiology, and antibiotic treatment.Data Sources:… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
10
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 63 publications
3
10
0
1
Order By: Relevance
“…In the future large prospective studies should be done to clarify the role of COPD on the outcome of CAP [ 2 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the future large prospective studies should be done to clarify the role of COPD on the outcome of CAP [ 2 ].…”
Section: Discussionmentioning
confidence: 99%
“…Community acquired pneumonia (CAP) is an infection of the pulmonary parenchyma that results in a huge economic and health burden [ 1 ]. It is a major cause of hospitalizations, morbidity, and mortality [ 2 ]. Chronic obstructive pulmonary disease (COPD) increases the susceptibility to CAP [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, this could also hide other clinical patterns such as therapy. For example, COPD patients on inhaled corticosteroids may have worse outcomes, including death, in the presence of community-acquired pneumonia ( Liu, Han & Liu, 2018 ). To the best of our knowledge there is no evidence on mortality or treatment patterns in COPD patients in Peru.…”
Section: Discussionmentioning
confidence: 99%
“…For example, COPD patients on inhaled corticosteroids may have worse outcomes, including death, in the presence of community-acquired pneumonia. (Liu et al 2018) To the best of our knowledge there is no evidence on mortality or treatment patters in COPD patients in Peru. Although largely speculative, if inhaled corticosteroids were the leading treatment this could explain our results.…”
Section: Comparison With Available Evidence and Interpretation Of Resmentioning
confidence: 98%